ProPhase Labs (ProPhase Labs) Days Inventory

: 61.91 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). ProPhase Labs's Average Total Inventories for the three months ended in Dec. 2023 was $4.45 Mil. ProPhase Labs's Cost of Goods Sold for the three months ended in Dec. 2023 was $6.56 Mil. Hence, ProPhase Labs's Days Inventory for the three months ended in Dec. 2023 was 61.91.

The historical rank and industry rank for ProPhase Labs's Days Inventory or its related term are showing as below:

PRPH' s Days Inventory Range Over the Past 10 Years
Min: 30.1 Med: 83.68 Max: 825.15
Current: 53.96

During the past 13 years, ProPhase Labs's highest Days Inventory was 825.15. The lowest was 30.10. And the median was 83.68.

PRPH's Days Inventory is ranked better than
55.44% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.4 vs PRPH: 53.96

ProPhase Labs's Days Inventory increased from Dec. 2022 (38.47) to Dec. 2023 (61.91). It might indicate that ProPhase Labs's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. ProPhase Labs's Inventory Turnover for the three months ended in Dec. 2023 was 1.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ProPhase Labs's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.27.

ProPhase Labs Days Inventory Historical Data

The historical data trend for ProPhase Labs's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProPhase Labs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

84.50

82.85

37.62

30.10

50.69

ProPhase Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory																38.47	43.05	53.48	65.57	61.91

Competitive Comparison

For the Diagnostics & Research subindustry, ProPhase Labs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProPhase Labs Days Inventory Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, ProPhase Labs's Days Inventory distribution charts can be found below:

* The bar in red indicates where ProPhase Labs's Days Inventory falls into.

ProPhase Labs Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ProPhase Labs's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.976	+	3.841)	/	2 )	/	28.145	*	365
=	3.9085					/	28.145	*	365
=	50.69

ProPhase Labs's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (5.054	+	3.841)	/	2 )	/	6.555	*	365 / 4
=	4.4475					/	6.555	*	365 / 4
=	61.91

ProPhase Labs (NAS:PRPH) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

ProPhase Labs's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	6.555	/	4.4475
	=	1.47

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ProPhase Labs's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	4.4475	/	3.499
	=	1.27

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

ProPhase Labs Days Inventory Related Terms

Thank you for viewing the detailed overview of ProPhase Labs's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

ProPhase Labs (ProPhase Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ProPhase Labs Inc (NAS:PRPH) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

711 Stewart Avenue, Suite 200, Garden City, NY, USA, 11530

Website

https://www.prophaselabs.com

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Executives

Morse Robert A. Jr.	officer: Controller	711 STEWART AVENUE, SUITE 200, GARDEN CITY NY 11530
Billy Joe White	officer: Chief Financial Officer	191 OTTO ST., PORT TOWNSEND WA 98368
Jason Michael Barr	director	902 BROADWAY, 15TH FLOOR, NEW YORK NY 10010
Louis Md Gleckel	10 percent owner	C/O PROHEALTH CARE ASSOCIATES LLP, 2800 METRUS AVE, LAKE SUCCESS NY 11042
Ted William Karkus	10 percent owner	188 HEWLETT NECK ROAD, WOODMERE NY 11598
Warren Hirsch	director	621 N. SHADY RETREAT ROAD, DOYLESTOWN PA 18901
Monica L. Brady	officer: Chief Accounting Officer	621 N. SHADY RETREAT ROAD, DOYLESTOWN PA 18901
Cuddihy Robert V Jr	officer: Chief Operating Officer	PARKER DURYEE ET AL, 529 FIFTH AVE 8TH FL, NEW YORK NY 10017
Braden Michael Leonard	10 percent owner	156 S. FIRST STREET, ZIONSVILLE IN 46077
Mark S Leventhal	10 percent owner	THE BEACON COMPANIES, 50 FEDERAL STREET, BOSTON MA 02468
Mark Shawn Frank	director	104 WHISPER WOOD COURT, WRIGHTSTOWN PA 18940
James T Mccubbin	director
Mark A. Burnett	10 percent owner	40 HEMLOCK DRIVE, ROSLYN NY 11576
Guy J Quigley	director, 10 percent owner, officer: Chairman, President, CEO	C/O THE QUIGLEY CORP KELLS BUILDINGS, 621 SHADY RETREAT RD P O BOX 1349, DOYLESTOWN PA 18901
John Deshazo	10 percent owner	17 WOLCOTT COURT, BOSTON MA 02136